1. Home
  2. MNTK vs ALT Comparison

MNTK vs ALT Comparison

Compare MNTK & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNTK
  • ALT
  • Stock Information
  • Founded
  • MNTK 1980
  • ALT 1997
  • Country
  • MNTK United States
  • ALT United States
  • Employees
  • MNTK N/A
  • ALT N/A
  • Industry
  • MNTK Natural Gas Distribution
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNTK Utilities
  • ALT Health Care
  • Exchange
  • MNTK Nasdaq
  • ALT Nasdaq
  • Market Cap
  • MNTK 306.2M
  • ALT 292.0M
  • IPO Year
  • MNTK 2021
  • ALT N/A
  • Fundamental
  • Price
  • MNTK $2.03
  • ALT $3.63
  • Analyst Decision
  • MNTK Hold
  • ALT Strong Buy
  • Analyst Count
  • MNTK 3
  • ALT 6
  • Target Price
  • MNTK $3.33
  • ALT $17.40
  • AVG Volume (30 Days)
  • MNTK 199.2K
  • ALT 3.0M
  • Earning Date
  • MNTK 08-06-2025
  • ALT 08-12-2025
  • Dividend Yield
  • MNTK N/A
  • ALT N/A
  • EPS Growth
  • MNTK N/A
  • ALT N/A
  • EPS
  • MNTK 0.02
  • ALT N/A
  • Revenue
  • MNTK $181,341,000.00
  • ALT $20,000.00
  • Revenue This Year
  • MNTK $2.49
  • ALT N/A
  • Revenue Next Year
  • MNTK $26.02
  • ALT $346,228.97
  • P/E Ratio
  • MNTK $109.52
  • ALT N/A
  • Revenue Growth
  • MNTK N/A
  • ALT N/A
  • 52 Week Low
  • MNTK $1.68
  • ALT $2.90
  • 52 Week High
  • MNTK $6.04
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • MNTK 45.96
  • ALT 40.61
  • Support Level
  • MNTK $1.93
  • ALT $3.34
  • Resistance Level
  • MNTK $2.11
  • ALT $3.91
  • Average True Range (ATR)
  • MNTK 0.13
  • ALT 0.20
  • MACD
  • MNTK -0.01
  • ALT 0.06
  • Stochastic Oscillator
  • MNTK 46.55
  • ALT 42.69

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: